Clinical Trials Browser

Phase 2 × Active not recruiting × gilteritinib × Clear all

NCT03836209 2025-06-15

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

Phase 2 Active not recruiting

181 enrolled 18 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute